Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Salit

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Blood Advances|August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populationsPaul A Carpenter, Ted A Gooley, Julie Boiko, et al.
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mei-Jie Zhang, Shannon R McCurdy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2017
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaH Joachim Deeg, Emily A Stevens, Rachel B Salit, et al.
The Lancet. Haematology|December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working GroupNicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research AnalysisNilanjan Ghosh, Reem Karmali, Vanderson Rocha, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Blood|March 20, 2023
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationNico Gagelmann, Anita Badbaran, Rachel B Salit, et al.
Blood Advances|August 21, 2024
Decreasing chronic graft-versus-host disease rates in all populationsPaul A Carpenter, Ted A Gooley, Julie Boiko, et al.
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mei-Jie Zhang, Shannon R McCurdy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2017
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid LeukemiaH Joachim Deeg, Emily A Stevens, Rachel B Salit, et al.
The Lancet. Haematology|December 7, 2023
Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working GroupNicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 25, 2014
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantationJason M Elinoff, Ulas Bagci, Brad Moriyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research AnalysisNilanjan Ghosh, Reem Karmali, Vanderson Rocha, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Pageof 5